Mutual Advisors LLC reduced its stake in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 11.2% in the 2nd quarter, HoldingsChannel.com reports. The fund owned 50,608 shares of the company’s stock after selling 6,407 shares during the quarter. Mutual Advisors LLC’s holdings in Procter & Gamble were worth $8,011,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently made changes to their positions in PG. Kingstone Capital Partners Texas LLC raised its stake in shares of Procter & Gamble by 655,209.0% in the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after acquiring an additional 76,017,350 shares during the last quarter. Nuveen LLC acquired a new stake in Procter & Gamble during the 1st quarter valued at $1,954,941,000. Price T Rowe Associates Inc. MD raised its position in Procter & Gamble by 13.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after purchasing an additional 2,466,308 shares during the last quarter. Invesco Ltd. boosted its stake in Procter & Gamble by 19.8% in the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock worth $2,299,580,000 after purchasing an additional 2,228,151 shares in the last quarter. Finally, Valeo Financial Advisors LLC increased its stake in shares of Procter & Gamble by 1,875.5% in the second quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company’s stock valued at $280,946,000 after buying an additional 1,674,139 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.
Procter & Gamble Price Performance
Procter & Gamble stock opened at $149.18 on Wednesday. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The firm has a market capitalization of $349.15 billion, a P/E ratio of 22.92, a PEG ratio of 3.91 and a beta of 0.36. The business has a 50-day moving average of $155.15 and a 200-day moving average of $159.20. Procter & Gamble Company has a 1 year low of $146.96 and a 1 year high of $180.43.
Procter & Gamble Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Friday, October 24th will be issued a $1.0568 dividend. The ex-dividend date of this dividend is Friday, October 24th. This represents a $4.23 annualized dividend and a dividend yield of 2.8%. Procter & Gamble’s payout ratio is 64.82%.
Insiders Place Their Bets
In other news, CEO Gary A. Coombe sold 3,535 shares of Procter & Gamble stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $538,133.05. Following the transaction, the chief executive officer owned 34,816 shares in the company, valued at $5,300,039.68. The trade was a 9.22% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Balaji Purushothaman sold 490 shares of the business’s stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $74,592.70. Following the completion of the transaction, the insider owned 12,616 shares of the company’s stock, valued at $1,920,533.68. This represents a 3.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 149,763 shares of company stock worth $23,421,279 over the last 90 days. 0.20% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
Several research analysts recently issued reports on the stock. BNP Paribas reiterated an “outperform” rating and set a $177.00 price target on shares of Procter & Gamble in a research report on Friday, August 15th. Bank of America reduced their target price on shares of Procter & Gamble from $180.00 to $174.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. UBS Group lowered their price target on shares of Procter & Gamble from $180.00 to $176.00 and set a “buy” rating for the company in a report on Wednesday, October 8th. Berenberg Bank upped their price objective on Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a report on Wednesday, September 17th. Finally, JPMorgan Chase & Co. decreased their price objective on Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating on the stock in a research report on Friday, October 10th. Eleven research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $172.21.
Check Out Our Latest Stock Report on PG
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also
- Five stocks we like better than Procter & Gamble
- How to Evaluate a Stock Before BuyingÂ
- After Gold Blast Soars Past $4,000, BofA Eyes $5,000 in 2026
- 3 Warren Buffett Stocks to Buy Now
- Buyback Boom: 3 Companies Betting Big on Themselves
- Buy P&G Now, Before It Sets A New All-Time High
- Analysts Flock to Upgrade DELL After Big AI-Server Guidance Boost
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.